Literature DB >> 9414160

The cellular prion protein binds copper in vivo.

D R Brown1, K Qin, J W Herms, A Madlung, J Manson, R Strome, P E Fraser, T Kruck, A von Bohlen, W Schulz-Schaeffer, A Giese, D Westaway, H Kretzschmar.   

Abstract

The normal cellular form of prion protein (PrPC) is a precursor to the pathogenic protease-resistant forms (PrPSc) believed to cause scrapie, bovine spongiform encephalopathy (BSE) and Creutzfeldt-Jakob disease. Its amino terminus contains the octapeptide PHGGGWGQ, which is repeated four times and is among the best-preserved regions of mammalian PrPC. Here we show that the amino-terminal domain of PrPC exhibits five to six sites that bind copper (Cu(II)) presented as a glycine chelate. At neutral pH, binding occurs with positive cooperativity, with binding affinity compatible with estimates for extracellular, labile copper. Two lines of independently derived PrPC gene-ablated (Prnp0/0) mice exhibit severe reductions in the copper content of membrane-enriched brain extracts and similar reductions in synaptosomal and endosome-enriched subcellular fractions. Prnp0/0 mice also have altered cellular phenotypes, including a reduction in the activity of copper/zinc superoxide dismutase and altered electrophysiological responses in the presence of excess copper. These findings indicate that PrPC can exist in a Cu-metalloprotein form in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9414160     DOI: 10.1038/37783

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  265 in total

1.  Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.

Authors:  L Zulianello; K Kaneko; M Scott; S Erpel; D Han; F E Cohen; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Consequences of manganese replacement of copper for prion protein function and proteinase resistance.

Authors:  D R Brown; F Hafiz; L L Glasssmith; B S Wong; I M Jones; C Clive; S J Haswell
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

3.  Normal prion protein has an activity like that of superoxide dismutase.

Authors:  D R Brown; B S Wong; F Hafiz; C Clive; S J Haswell; I M Jones
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

4.  Prion proteins and the gut: une liaison dangereuse?

Authors:  A N Shmakov; S Ghosh
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

5.  Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor.

Authors:  C Hundt; J M Peyrin; S Haïk; S Gauczynski; C Leucht; R Rieger; M L Riley; J P Deslys; D Dormont; C I Lasmézas; S Weiss
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

Review 6.  Protein aggregates and dementia: is there a common toxicity?

Authors:  S Lovestone; D M McLoughlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

7.  Location and properties of metal-binding sites on the human prion protein.

Authors:  G S Jackson; I Murray; L L Hosszu; N Gibbs; J P Waltho; A R Clarke; J Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

8.  Competing intrachain interactions regulate the formation of beta-sheet fibrils in bovine PrP peptides.

Authors:  Abdessamad Tahiri-Alaoui; Mario Bouchard; Jesús Zurdo; William James
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

Review 9.  Cellular prion protein: implications in seizures and epilepsy.

Authors:  Roger Walz; Rosa Maria R P S Castro; Tonicarlo R Velasco; Carlos G Carlotti; Américo C Sakamoto; Ricardo R Brentani; Vilma R Martins
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

10.  Dynamics of a truncated prion protein, PrP(113-231), from (15)N NMR relaxation: order parameters calculated and slow conformational fluctuations localized to a distinct region.

Authors:  Denis B D O'Sullivan; Christopher E Jones; Salama R Abdelraheim; Marcus W Brazier; Harold Toms; David R Brown; John H Viles
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.